Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome

Edmund C. Jenkins, Lingling Ye, Hong Gu, Samantha A. Ni, Charlotte J. Duncan, Milen Velinov, Deborah Pang, Sharon J. Krinsky-McHale, Warren B. Zigman, Nicole Schupf, Wayne P Silverman

Research output: Contribution to journalArticle

Abstract

We have reported previously that telomeres (ends of chromosomes consisting of highly conserved TTAGGG repeats) were shorter in metaphase and interphase preparations in T lymphocytes from short-term whole blood cultures of women with Down syndrome (DS) and dementia compared to age-matched women with DS but without dementia [E.C. Jenkins, M.T. Velinov, L. Ye, H. Gu, S. Li, E.C. Jenkins Jr., S.S. Brooks, D. Pang, D.A. Devenny, W.B. Zigman, N. Schupf, W.P. Silverman, Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia, Neurobiol. Aging 27 (2006) 41-45]. Our previous study was carried out by measuring changes in fluorescence intensity [using an FITC-labeled peptide nucleic acid (PNA) probe (Applied Biosystems; DAKO) and Applied Imaging software], and we now report on a substantially simpler metric, counts of signals at the ends of chromosomes. Nine adults with DS and dementia plus four who are exhibiting declines in cognition analogous to mild cognitive impairment in the general population (MCI-DS) were compared to their pair-matched peers with DS but without dementia or MCI-DS. Results indicated that the number of chromosome ends that failed to exhibit fluorescent signal from the PNA telomere probe was higher for people with dementia or mild cognitive impairment (MCI-DS). Thus, a simple count of chromosome ends for the "presence/absence" of fluorescence may provide a valid biomarker of dementia status. If this is the case, then after additional research for validation to assure high specificity and sensitivity, the test may be used to identify and ultimately guide treatment for people at increased risk for developing mild cognitive impairment and/or dementia.

Original languageEnglish (US)
Pages (from-to)340-343
Number of pages4
JournalNeuroscience Letters
Volume440
Issue number3
DOIs
StatePublished - Aug 8 2008

Fingerprint

Telomere
Down Syndrome
Dementia
Alzheimer Disease
Chromosomes
Nucleic Acid Probes
Peptide Nucleic Acids
Fluorescence
Telomere Shortening
T-Lymphocytes
Fluorescein-5-isothiocyanate
Interphase
Metaphase
Protein Sorting Signals
Cognition
Software
Biomarkers
Sensitivity and Specificity
Research
Population

Keywords

  • Alzheimer's disease
  • Down syndrome
  • Mild cognitive impairment
  • Telomere number

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. / Jenkins, Edmund C.; Ye, Lingling; Gu, Hong; Ni, Samantha A.; Duncan, Charlotte J.; Velinov, Milen; Pang, Deborah; Krinsky-McHale, Sharon J.; Zigman, Warren B.; Schupf, Nicole; Silverman, Wayne P.

In: Neuroscience Letters, Vol. 440, No. 3, 08.08.2008, p. 340-343.

Research output: Contribution to journalArticle

Jenkins, EC, Ye, L, Gu, H, Ni, SA, Duncan, CJ, Velinov, M, Pang, D, Krinsky-McHale, SJ, Zigman, WB, Schupf, N & Silverman, WP 2008, 'Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome', Neuroscience Letters, vol. 440, no. 3, pp. 340-343. https://doi.org/10.1016/j.neulet.2008.05.098
Jenkins, Edmund C. ; Ye, Lingling ; Gu, Hong ; Ni, Samantha A. ; Duncan, Charlotte J. ; Velinov, Milen ; Pang, Deborah ; Krinsky-McHale, Sharon J. ; Zigman, Warren B. ; Schupf, Nicole ; Silverman, Wayne P. / Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. In: Neuroscience Letters. 2008 ; Vol. 440, No. 3. pp. 340-343.
@article{652f6f3ffc4c413c9ead9d98f3c3a6da,
title = "Increased {"}absence{"} of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome",
abstract = "We have reported previously that telomeres (ends of chromosomes consisting of highly conserved TTAGGG repeats) were shorter in metaphase and interphase preparations in T lymphocytes from short-term whole blood cultures of women with Down syndrome (DS) and dementia compared to age-matched women with DS but without dementia [E.C. Jenkins, M.T. Velinov, L. Ye, H. Gu, S. Li, E.C. Jenkins Jr., S.S. Brooks, D. Pang, D.A. Devenny, W.B. Zigman, N. Schupf, W.P. Silverman, Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia, Neurobiol. Aging 27 (2006) 41-45]. Our previous study was carried out by measuring changes in fluorescence intensity [using an FITC-labeled peptide nucleic acid (PNA) probe (Applied Biosystems; DAKO) and Applied Imaging software], and we now report on a substantially simpler metric, counts of signals at the ends of chromosomes. Nine adults with DS and dementia plus four who are exhibiting declines in cognition analogous to mild cognitive impairment in the general population (MCI-DS) were compared to their pair-matched peers with DS but without dementia or MCI-DS. Results indicated that the number of chromosome ends that failed to exhibit fluorescent signal from the PNA telomere probe was higher for people with dementia or mild cognitive impairment (MCI-DS). Thus, a simple count of chromosome ends for the {"}presence/absence{"} of fluorescence may provide a valid biomarker of dementia status. If this is the case, then after additional research for validation to assure high specificity and sensitivity, the test may be used to identify and ultimately guide treatment for people at increased risk for developing mild cognitive impairment and/or dementia.",
keywords = "Alzheimer's disease, Down syndrome, Mild cognitive impairment, Telomere number",
author = "Jenkins, {Edmund C.} and Lingling Ye and Hong Gu and Ni, {Samantha A.} and Duncan, {Charlotte J.} and Milen Velinov and Deborah Pang and Krinsky-McHale, {Sharon J.} and Zigman, {Warren B.} and Nicole Schupf and Silverman, {Wayne P}",
year = "2008",
month = "8",
day = "8",
doi = "10.1016/j.neulet.2008.05.098",
language = "English (US)",
volume = "440",
pages = "340--343",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome

AU - Jenkins, Edmund C.

AU - Ye, Lingling

AU - Gu, Hong

AU - Ni, Samantha A.

AU - Duncan, Charlotte J.

AU - Velinov, Milen

AU - Pang, Deborah

AU - Krinsky-McHale, Sharon J.

AU - Zigman, Warren B.

AU - Schupf, Nicole

AU - Silverman, Wayne P

PY - 2008/8/8

Y1 - 2008/8/8

N2 - We have reported previously that telomeres (ends of chromosomes consisting of highly conserved TTAGGG repeats) were shorter in metaphase and interphase preparations in T lymphocytes from short-term whole blood cultures of women with Down syndrome (DS) and dementia compared to age-matched women with DS but without dementia [E.C. Jenkins, M.T. Velinov, L. Ye, H. Gu, S. Li, E.C. Jenkins Jr., S.S. Brooks, D. Pang, D.A. Devenny, W.B. Zigman, N. Schupf, W.P. Silverman, Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia, Neurobiol. Aging 27 (2006) 41-45]. Our previous study was carried out by measuring changes in fluorescence intensity [using an FITC-labeled peptide nucleic acid (PNA) probe (Applied Biosystems; DAKO) and Applied Imaging software], and we now report on a substantially simpler metric, counts of signals at the ends of chromosomes. Nine adults with DS and dementia plus four who are exhibiting declines in cognition analogous to mild cognitive impairment in the general population (MCI-DS) were compared to their pair-matched peers with DS but without dementia or MCI-DS. Results indicated that the number of chromosome ends that failed to exhibit fluorescent signal from the PNA telomere probe was higher for people with dementia or mild cognitive impairment (MCI-DS). Thus, a simple count of chromosome ends for the "presence/absence" of fluorescence may provide a valid biomarker of dementia status. If this is the case, then after additional research for validation to assure high specificity and sensitivity, the test may be used to identify and ultimately guide treatment for people at increased risk for developing mild cognitive impairment and/or dementia.

AB - We have reported previously that telomeres (ends of chromosomes consisting of highly conserved TTAGGG repeats) were shorter in metaphase and interphase preparations in T lymphocytes from short-term whole blood cultures of women with Down syndrome (DS) and dementia compared to age-matched women with DS but without dementia [E.C. Jenkins, M.T. Velinov, L. Ye, H. Gu, S. Li, E.C. Jenkins Jr., S.S. Brooks, D. Pang, D.A. Devenny, W.B. Zigman, N. Schupf, W.P. Silverman, Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia, Neurobiol. Aging 27 (2006) 41-45]. Our previous study was carried out by measuring changes in fluorescence intensity [using an FITC-labeled peptide nucleic acid (PNA) probe (Applied Biosystems; DAKO) and Applied Imaging software], and we now report on a substantially simpler metric, counts of signals at the ends of chromosomes. Nine adults with DS and dementia plus four who are exhibiting declines in cognition analogous to mild cognitive impairment in the general population (MCI-DS) were compared to their pair-matched peers with DS but without dementia or MCI-DS. Results indicated that the number of chromosome ends that failed to exhibit fluorescent signal from the PNA telomere probe was higher for people with dementia or mild cognitive impairment (MCI-DS). Thus, a simple count of chromosome ends for the "presence/absence" of fluorescence may provide a valid biomarker of dementia status. If this is the case, then after additional research for validation to assure high specificity and sensitivity, the test may be used to identify and ultimately guide treatment for people at increased risk for developing mild cognitive impairment and/or dementia.

KW - Alzheimer's disease

KW - Down syndrome

KW - Mild cognitive impairment

KW - Telomere number

UR - http://www.scopus.com/inward/record.url?scp=45849112500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45849112500&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2008.05.098

DO - 10.1016/j.neulet.2008.05.098

M3 - Article

C2 - 18571319

AN - SCOPUS:45849112500

VL - 440

SP - 340

EP - 343

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -